Will Insurance Cover Your Stem Cell Injections? Key Facts

Stem cell injections are being marketed for knee arthritis, back pain, sports injuries, and dozens of other conditions. The pitch often sounds simple: use your own cells to heal instead of relying on surgery or steroids. The bill is rarely simple. In most cases, insurance does not cover stem cell injections, and the few exceptions are narrow. Understanding why comes down to how the FDA regulates these products and how insurers decide what to pay for.

Will Insurance Cover Your Stem Cell Injections?

For the vast majority of stem cell injections offered in the US, the answer is no. Insurance companies classify most of these procedures as investigational or experimental, which means they fall outside covered benefits.

There is one well-established exception. Hematopoietic stem cell transplants — used to treat certain blood cancers and some immune and genetic disorders — are covered by most insurers when performed for an approved medical indication. That is a different procedure from the injections marketed for joints, tendons, and spine pain.

The distinction matters. A bone marrow transplant for leukemia is a decades-old, evidence-based treatment. An injection of your own bone marrow cells into a knee is not the same thing, even though both get called “stem cell therapy.”

Why Do Insurers Call Most Stem Cell Injections Experimental?

Insurers base coverage on whether a treatment has proven safe and effective for a specific condition. For most orthopedic and pain uses, that proof is still missing.

Stem cell injections for arthritis, tendon injuries, and disc problems have been studied, but the results are mixed. Many studies are small. Some lack a control group, meaning no one received a placebo injection for comparison. Others show improvement in both the treated and control groups, which makes it hard to separate the treatment effect from the natural course of the condition or a placebo response.

There is also a practical problem. The products themselves vary widely. Some clinics use bone marrow aspirate. Some use fat tissue. Some use cells from umbilical cord blood or amniotic tissue. The number of live cells, the processing method, and the injection technique differ from clinic to clinic. That variability makes it hard to run the kind of large, standardized trials insurers want before they agree to pay.

Some clinicians argue that these injections help certain patients and that waiting for perfect trials delays access. That position is reasonable to raise. It is not the same as saying the evidence is settled, because it is not.

What About FDA-Approved Stem Cell Products?

As of now, there are very few FDA-approved stem cell products, and the ones that exist are for specific uses like certain blood cancers and immune conditions. They are not approved for treating knee arthritis or back pain.

This creates a confusing situation. A clinic can legally offer a procedure using your own cells under certain conditions, because the FDA generally does not regulate cells that are removed from your body, minimally manipulated, and reinserted during the same procedure. That does not mean the FDA has approved the procedure as safe and effective. It means the procedure falls outside the agency’s approval pathway.

Marketing language often blurs this line. A clinic might say “FDA-registered” or “FDA-compliant.” Those terms describe how a facility or product is handled, not whether the treatment has been proven to work. Registration is not approval.

Which Stem Cell Treatments Are Usually Covered?

Coverage exists for procedures with strong evidence behind them. These include:

• Hematopoietic stem cell transplant for certain leukemias, lymphomas, and multiple myeloma
• Bone marrow transplant for some inherited blood and immune disorders
• Certain approved cellular therapies for specific cancers, when they meet clinical criteria

Even here, coverage depends on the diagnosis, the patient’s health, and whether the treatment follows accepted guidelines. Insurers typically require prior authorization and often require that the patient has tried standard treatments first.

Notice what is missing from that list: joint injections, spine injections, and cosmetic or anti-aging uses. Those are almost never covered.

Can You Appeal a Denial?

Yes, and sometimes it works. But the odds depend heavily on what is being requested and why.

An appeal is more likely to succeed when the treatment is an established therapy, when it is being used for an FDA-approved indication, and when the patient’s doctor documents medical necessity in detail. An appeal for an unproven joint injection is a much harder case, because the insurer’s core objection — lack of proof — is the same one a reviewer will see on appeal.

If you decide to appeal, the process usually looks like this:

• Ask for the denial in writing and find the specific reason given
• Request your doctor send a letter explaining the medical rationale
• Include any published studies your doctor believes support the treatment
• Follow the insurer’s stated deadline for appeals
• Ask whether an external review is available if the internal appeal fails

An external review uses an independent reviewer outside the insurance company. It does not guarantee a different outcome, but it is a real option in many plans.

What Do Stem Cell Injections Actually Cost?

Because insurance rarely pays, most patients face the full cost. Prices vary widely by clinic, city, and what is being injected. Some clinics charge a few thousand dollars per injection. Others charge considerably more. Some bundle multiple injections or add “booster” treatments for an additional fee.

Be cautious with pricing claims. A higher price does not mean a better or more proven treatment. There is no standard pricing for these procedures because there is no standard procedure.

It is also worth asking what happens if the injection does not help. Some clinics offer refunds or repeat injections. Many do not. Get any promise in writing before you pay.

What Are the Risks of Paying Out of Pocket?

The financial risk is obvious. The medical risks are less discussed but real.

Any injection into a joint or spine carries a small risk of infection, bleeding, or injury to nearby tissue. There is also the risk that a procedure marketed as a treatment turns out to be ineffective, delaying a treatment that is known to work.

There have been reports of serious harm from unregulated stem cell clinics, including infections and, in rare cases, tumors. These events are uncommon, but they are a reminder that “using your own cells” does not automatically make a procedure safe.

If a clinic promises to cure a condition, guarantees results, or discourages you from asking about evidence, that is a warning sign. So is any clinic that suggests you stop a proven treatment in favor of injections.

How Should You Decide?

Start by asking what the evidence actually shows for your specific condition, not for stem cell therapy in general. Those are different questions.

Ask your doctor whether the injection is FDA-approved for your condition, whether it is covered by your plan, and what standard treatments exist that have stronger evidence. Get a second opinion if the recommendation comes from the clinic selling the procedure.

If you are considering paying out of pocket, treat it like any other major purchase. Ask for the total cost in writing. Ask what is included. Ask what happens if it does not work. And be honest with yourself about whether you can afford to lose that money, because there is a real chance the injection will not help.

None of this means stem cell research is not promising. It is. Scientists are studying these approaches for many conditions, and some results are encouraging. But promising research and proven treatment are not the same thing, and insurance companies pay for the second, not the first.